Found 10 matching trials
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial PHASE3 This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer PHASE2 This is a phase II, open-label, non-randomized study in subjects with histo...
Show More Location
University of Arizona Cancer Center
Learn More & Join Trial
FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI) PHASE2 The aim of the trial is to optimize response rates and rates of secondary r...
Show More Location
Klinikum Esslingen
Learn More & Join Trial
Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study PHASE2 This prospective Phase II study aims to evaluate the efficacy and safety of...
Show More Location
Al Hussien University Hospital
Learn More & Join Trial
Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer PHASE2 The purpose of the present study is to investigate the benefit of anti-canc...
Show More Location
Department of Oncology, Aalborg University Hospital
Learn More & Join Trial
Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases PHASE4 Main outcome: Assess the impact of cancer-related survival at 2 years in pa...
Show More Location
Hospital Universitario Araba
Learn More & Join Trial
Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases PHASE3 Colorectal cancer patients with initially unresectable liver-only metastase...
Show More Location
Universitair ziekenhuis Antwerpen
Learn More & Join Trial
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only PHASE2 In this Phase II study the investigators plan to determine the overall resp...
Show More Location
NEA Baptist Clinic
Learn More & Join Trial
RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer NA This study aims to assess the clinical benefit of local ablative therapy (L...
Show More Status
Active Not Recruiting
Location
Border Medical Oncology
Learn More & Join Trial
FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer PHASE2 The GONO-FOLFOXIRI regimen demonstrated higher activity and efficacy compar...
Show More Location
P.O. Zona Aretina - Ospedale S. Donato Di Arezzo
Learn More & Join Trial